BAMS
Bellevue Asset Management (Switzerland) Portfolio holdings
AUM
$656M
This Quarter Return
+4.86%
1 Year Return
+11.48%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$721M
AUM Growth
+$721M
(+0.55%)
Cap. Flow
-$22.1M
Cap. Flow
% of AUM
-3.06%
Top 10 Holdings %
Top 10 Hldgs %
29.13%
Holding
154
New
13
Increased
38
Reduced
45
Closed
14
Top Buys
| 1 |
Illumina
ILMN
|
$5.94M |
| 2 |
ENDP
Endo International plc
ENDP
|
$5.73M |
| 3 |
Cencora
COR
|
$5.32M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$5.21M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$5.21M |
Top Sells
| 1 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
$18.9M |
| 2 |
Baxter International
BAX
|
$9.56M |
| 3 |
Centene
CNC
|
$9.48M |
| 4 |
LCI
Lannett Company, Inc.
LCI
|
$6.61M |
| 5 |
Molina Healthcare
MOH
|
$6.39M |
Sector Composition
| 1 | Healthcare | 90.06% |
| 2 | Financials | 0.8% |
| 3 | Industrials | 0.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Elevance Health
ELV
$71.8B
| $4.92M | 0.68% |
30,000
| – | – |
|
52
Johnson & Johnson
JNJ
$427B
| $4.87M | 0.68% |
50,000
+10,000
| +25% | +$975K |
|
53
Edwards Lifesciences
EW
$47.8B
| $4.86M | 0.67% |
34,100
+19,600
| +135% | +$2.79M |
|
|
CLVS
54
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.84M | 0.67% |
55,100
+13,000
| +31% | +$1.14M |
|
55
Agios Pharmaceuticals
AGIO
$2.19B
| $4.56M | 0.63% |
41,000
-17,000
| -29% | -$1.89M |
|
56
Humana
HUM
$36.5B
| $4.5M | 0.62% |
23,500
-1,500
| -6% | -$287K |
|
|
INSY
57
DELISTED
Insys Therapeutics, Inc.
INSY
| $4.31M | 0.6% |
+120,000
| New | +$4.31M |
|
58
Acadia Pharmaceuticals
ACAD
$4.38B
| $4.23M | 0.59% |
101,000
-130,000
| -56% | -$5.44M |
|
|
ARIA
59
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $4.09M | 0.57% |
495,000
-34,000
| -6% | -$281K |
|
60
Teleflex
TFX
$5.59B
| $4.06M | 0.56% |
30,000
| – | – |
|
61
Bristol-Myers Squibb
BMY
$96B
| $3.99M | 0.55% |
60,000
| – | – |
|
62
Merck
MRK
$210B
| $3.99M | 0.55% |
70,000
+30,000
| +75% | +$1.71M |
|
|
CERN
63
DELISTED
Cerner Corp
CERN
| $3.8M | 0.53% |
55,000
-11,000
| -17% | -$760K |
|
|
XENT
64
DELISTED
Intersect ENT, Inc
XENT
| $3.72M | 0.52% |
130,000
+56,200
| +76% | +$1.61M |
|
65
HCA Healthcare
HCA
$94.5B
| $3.63M | 0.5% |
40,000
-27,000
| -40% | -$2.45M |
|
|
VAR
66
DELISTED
Varian Medical Systems, Inc.
VAR
| $3.54M | 0.49% |
42,000
-5,000
| -11% | -$422K |
|
|
BLUE
67
DELISTED
bluebird bio
BLUE
| $3.37M | 0.47% |
20,000
+6,000
| +43% | +$1.01M |
|
68
Pfizer
PFE
$141B
| $3.35M | 0.47% |
100,000
-80,000
| -44% | -$2.68M |
|
|
ACHN
69
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $3.33M | 0.46% |
376,000
-70,000
| -16% | -$620K |
|
70
Cooper Companies
COO
$13.4B
| $3.29M | 0.46% |
18,500
| – | – |
|
71
Neurocrine Biosciences
NBIX
$13.8B
| $3.1M | 0.43% |
65,000
+25,000
| +63% | +$1.19M |
|
72
Hologic
HOLX
$14.9B
| $3.08M | 0.43% |
81,000
| – | – |
|
73
MacroGenics
MGNX
$112M
| $3.08M | 0.43% |
81,000
+66,000
| +440% | +$2.51M |
|
74
Dentsply Sirona
XRAY
$2.85B
| $3.01M | 0.42% |
58,400
+16,400
| +39% | +$846K |
|
75
Masimo
MASI
$7.59B
| $2.91M | 0.4% |
75,000
+25,000
| +50% | +$969K |
|